Clinical Validation of PROPECG-TMT

Yonsei University

Status: Completed

Conditions: Coronary Artery Disease

Treatments: Other: Screening for coronary artery revascularization based on TMT-ECG

Study type: Observational

Funder types: Other

Identifiers

NCT06624852

4-2023-0086

Details and patient eligibility

About

This clinical validation evaluates the performances of physicians with and without learning with PROPECG-TMT assistance for screening coronary artery revascularization on TMT-ECG.

There are two endpoints used to evaluate performances: Accuracy (primary endpoints with pair specificity/sensitivity, and PPV/NPV), and time needed for screening (secondary endpoints with time measurements in all cases).

Enrollment: 100 patients

Sex: All

Ages: 21 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• TMT ECG exams adjudicated as equivocal cases

Exclusion criteria

• Exams not converting to median beat ECG
• Exams not containing interpretable exercise

Trial design

100 participants in 2 patient groups

Performances with AI assistance

Description:

Performances of screening coronary artery revascularization with PROPECG-TMT

Treatment:

Other: Screening for coronary artery revascularization based on TMT-ECG

Performances without AI assistance

Description:

Performances of screening coronary artery revascularization without PROPECG-TMT

Treatment:

Other: Screening for coronary artery revascularization based on TMT-ECG